223 related articles for article (PubMed ID: 30141278)
1. Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study.
Tran-Duy A; Connell NJ; Vanmolkot FH; Souverein PC; de Wit NJ; Stehouwer CDA; Hoes AW; de Vries F; de Boer A
J Intern Med; 2019 Feb; 285(2):205-214. PubMed ID: 30141278
[TBL] [Abstract][Full Text] [Related]
2. Effect of long-term proton pump inhibitor therapy on hemoglobin and serum iron levels after sleeve gastrectomy.
Sharma N; Chau WY; Dobruskin L
Surg Obes Relat Dis; 2019 Oct; 15(10):1682-1689. PubMed ID: 31422079
[TBL] [Abstract][Full Text] [Related]
3. The association between proton pump inhibitor use and the risk of tuberculosis: A case-control study.
Song HJ; Park H; Park S; Kwon JW
Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):830-839. PubMed ID: 30920070
[TBL] [Abstract][Full Text] [Related]
4. Association between proton pump inhibitor use and anemia: a retrospective cohort study.
Sarzynski E; Puttarajappa C; Xie Y; Grover M; Laird-Fick H
Dig Dis Sci; 2011 Aug; 56(8):2349-53. PubMed ID: 21318590
[TBL] [Abstract][Full Text] [Related]
5. Proton Pump Inhibitor and Histamine-2 Receptor Antagonist Use and Iron Deficiency.
Lam JR; Schneider JL; Quesenberry CP; Corley DA
Gastroenterology; 2017 Mar; 152(4):821-829.e1. PubMed ID: 27890768
[TBL] [Abstract][Full Text] [Related]
6. Co-prescribing of proton pump inhibitors among chronic users of NSAIDs in the UK.
Suh DC; Hunsche E; Shin HC; Mavros P
Rheumatology (Oxford); 2008 Apr; 47(4):458-63. PubMed ID: 18263598
[TBL] [Abstract][Full Text] [Related]
7. Using proton pump inhibitors correlates with an increased risk of chronic kidney disease: a nationwide database-derived case-controlled study.
Hung SC; Liao KF; Hung HC; Lin CL; Lai SW; Lee PC; Hung SR
Fam Pract; 2018 Mar; 35(2):166-171. PubMed ID: 29045621
[TBL] [Abstract][Full Text] [Related]
8. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.
Freedberg DE; Haynes K; Denburg MR; Zemel BS; Leonard MB; Abrams JA; Yang YX
Osteoporos Int; 2015 Oct; 26(10):2501-7. PubMed ID: 25986385
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors and risk of periampullary cancers--A nested case-control study.
Chien LN; Huang YJ; Shao YH; Chang CJ; Chuang MT; Chiou HY; Yen Y
Int J Cancer; 2016 Mar; 138(6):1401-9. PubMed ID: 26488896
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitor use represents an independent risk factor for myocardial infarction.
Shih CJ; Chen YT; Ou SM; Li SY; Chen TJ; Wang SJ
Int J Cardiol; 2014 Nov; 177(1):292-7. PubMed ID: 25499395
[TBL] [Abstract][Full Text] [Related]
11. Use of proton pump inhibitors and risk of ischemic events in the general population.
Casula M; Scotti L; Galimberti F; Mozzanica F; Tragni E; Corrao G; Catapano AL
Atherosclerosis; 2018 Oct; 277():123-129. PubMed ID: 30212680
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitor-related headaches: a nationwide population-based case-crossover study in Taiwan.
Liang JF; Chen YT; Fuh JL; Li SY; Chen TJ; Tang CH; Wang SJ
Cephalalgia; 2015 Mar; 35(3):203-10. PubMed ID: 24853165
[TBL] [Abstract][Full Text] [Related]
13. Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.
Wang YF; Chen YT; Luo JC; Chen TJ; Wu JC; Wang SJ
Am J Gastroenterol; 2017 Jul; 112(7):1084-1093. PubMed ID: 28397874
[TBL] [Abstract][Full Text] [Related]
14. Iron-deficiency anemia caused by a proton pump inhibitor.
Hashimoto R; Matsuda T; Chonan A
Intern Med; 2014; 53(20):2297-9. PubMed ID: 25318791
[TBL] [Abstract][Full Text] [Related]
15. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study.
Zipursky J; Macdonald EM; Hollands S; Gomes T; Mamdani MM; Paterson JM; Lathia N; Juurlink DN
PLoS Med; 2014 Sep; 11(9):e1001736. PubMed ID: 25268962
[TBL] [Abstract][Full Text] [Related]
17. [Validity of proton pump inhibitors' prescriptions in a department of internal medicine].
Marie I; Moutot A; Tharrasse A; Hellot MF; Robaday S; Hervé F; Lévesque H
Rev Med Interne; 2007 Feb; 28(2):86-93. PubMed ID: 17092611
[TBL] [Abstract][Full Text] [Related]
18. Determining proton pump inhibitor prescription dispensing patterns and adherence to STOPP criteria for Nova Scotia Seniors Pharmacare Program beneficiaries.
Carter JH; Sketris IS; Tamim H; Levy AR; Langley JM
J Popul Ther Clin Pharmacol; 2019 Dec; 26(4):e37-e53. PubMed ID: 31909577
[TBL] [Abstract][Full Text] [Related]
19. Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study.
Othman F; Crooks CJ; Card TR
BMJ; 2016 Nov; 355():i5813. PubMed ID: 28715344
[No Abstract] [Full Text] [Related]
20. Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands.
van Boxel OS; Hagenaars MP; Smout AJ; Siersema PD
Aliment Pharmacol Ther; 2009 Mar; 29(5):571-9. PubMed ID: 19035978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
